Heart failure management guidelines: New recommendations and implementation
J Cardiol. 2023 Nov 8:S0914-5087(23)00271-X. doi: 10.1016/j.jjcc.2023.10.009. Online ahead of print.ABSTRACTThe prevalence of heart failure has increased in many developed countries including Japan and the USA, due in large part to the aging of their populations. The lifetime risk of heart failure is now 20-30 % in the USA. Fortunately, there have been important advances in therapy that increase quality and length of life for those with heart failure. This review discusses the important advances in care including treatment and diagnosis and the new recommendations for this care from the recent American College of Cardiolog...
Source: Journal of Cardiology - November 10, 2023 Category: Cardiology Authors: Paul Heidenreich Source Type: research
Effect of increase in heart rate after anthracycline chemotherapy on subsequent left ventricular dysfunction
CONCLUSIONS: Our findings may have a novel effect on the management of cancer patients scheduled for anthracycline chemotherapy.PMID:37949314 | DOI:10.1016/j.jjcc.2023.11.001 (Source: Journal of Cardiology)
Source: Journal of Cardiology - November 10, 2023 Category: Cardiology Authors: Masayuki Kintsu Susumu Odajima Kimikazu Takeuchi Yasushi Ichikawa Saki Todo Eri Ota Yuki Yamauchi Hiroaki Shiraki Kentaro Yamashita Terunobu Fukuda Eriko Hisamatsu Hironobu Minami Ken-Ichi Hirata Hidekazu Tanaka Source Type: research
Clinical impacts of CT-derived fractional flow reserve under insurance reimbursement: Results from multicenter, prospective registry
CONCLUSION: Introduction of FFRCT could not only reduce unnecessary ICA and be a test that replaces the conventional non-invasive functional assessment modality but also result in medical cost reduction even when used under real Japanese insurance reimbursement.PMID:37949315 | DOI:10.1016/j.jjcc.2023.11.002 (Source: Journal of Cardiology)
Source: Journal of Cardiology - November 10, 2023 Category: Cardiology Authors: Shinichiro Fujimoto Yui O Nozaki Tomohiro Sakamoto Rine Nakanishi Taku Asano Kazushige Kadota Kota Komiyama Eiji Taguchi Ryo Okubo Akira Saito Akihiro Ikuta Shuko Nojiri Kengo Tanabe Source Type: research
Heart failure management guidelines: New recommendations and implementation
J Cardiol. 2023 Nov 8:S0914-5087(23)00271-X. doi: 10.1016/j.jjcc.2023.10.009. Online ahead of print.ABSTRACTThe prevalence of heart failure has increased in many developed countries including Japan and the USA, due in large part to the aging of their populations. The lifetime risk of heart failure is now 20-30 % in the USA. Fortunately, there have been important advances in therapy that increase quality and length of life for those with heart failure. This review discusses the important advances in care including treatment and diagnosis and the new recommendations for this care from the recent American College of Cardiolog...
Source: Journal of Cardiology - November 10, 2023 Category: Cardiology Authors: Paul Heidenreich Source Type: research
Effect of increase in heart rate after anthracycline chemotherapy on subsequent left ventricular dysfunction
CONCLUSIONS: Our findings may have a novel effect on the management of cancer patients scheduled for anthracycline chemotherapy.PMID:37949314 | DOI:10.1016/j.jjcc.2023.11.001 (Source: Journal of Cardiology)
Source: Journal of Cardiology - November 10, 2023 Category: Cardiology Authors: Masayuki Kintsu Susumu Odajima Kimikazu Takeuchi Yasushi Ichikawa Saki Todo Eri Ota Yuki Yamauchi Hiroaki Shiraki Kentaro Yamashita Terunobu Fukuda Eriko Hisamatsu Hironobu Minami Ken-Ichi Hirata Hidekazu Tanaka Source Type: research
Clinical impacts of CT-derived fractional flow reserve under insurance reimbursement: Results from multicenter, prospective registry
CONCLUSION: Introduction of FFRCT could not only reduce unnecessary ICA and be a test that replaces the conventional non-invasive functional assessment modality but also result in medical cost reduction even when used under real Japanese insurance reimbursement.PMID:37949315 | DOI:10.1016/j.jjcc.2023.11.002 (Source: Journal of Cardiology)
Source: Journal of Cardiology - November 10, 2023 Category: Cardiology Authors: Shinichiro Fujimoto Yui O Nozaki Tomohiro Sakamoto Rine Nakanishi Taku Asano Kazushige Kadota Kota Komiyama Eiji Taguchi Ryo Okubo Akira Saito Akihiro Ikuta Shuko Nojiri Kengo Tanabe Source Type: research
Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device
J Cardiol. 2023 Nov 3:S0914-5087(23)00270-8. doi: 10.1016/j.jjcc.2023.10.008. Online ahead of print.ABSTRACTThe importance of temporary mechanical circulatory support for treating acute heart failure with cardiogenic shock is increasingly recognized, and Impella (Abiomed, Danvers, MA, USA) has received particular attention in this regard. Impella is an axial flow left ventricular assist device (LVAD) built into the tip of a catheter. It is inserted via a peripheral artery and implanted into the left ventricle. Although the morphology of Impella is different from a typical LVAD, it has similar actions and effects as an LVAD...
Source: Journal of Cardiology - November 5, 2023 Category: Cardiology Authors: Shunsuke Saito Shohei Okubo Taiki Matsuoka Shotaro Hirota Shohei Yokoyama Yuta Kanazawa Yusuke Takei Masahiro Tezuka Go Tsuchiya Taisuke Konishi Ikuko Shibasaki Koji Ogata Hirotsugu Fukuda Source Type: research
Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device
J Cardiol. 2023 Nov 3:S0914-5087(23)00270-8. doi: 10.1016/j.jjcc.2023.10.008. Online ahead of print.ABSTRACTThe importance of temporary mechanical circulatory support for treating acute heart failure with cardiogenic shock is increasingly recognized, and Impella (Abiomed, Danvers, MA, USA) has received particular attention in this regard. Impella is an axial flow left ventricular assist device (LVAD) built into the tip of a catheter. It is inserted via a peripheral artery and implanted into the left ventricle. Although the morphology of Impella is different from a typical LVAD, it has similar actions and effects as an LVAD...
Source: Journal of Cardiology - November 5, 2023 Category: Cardiology Authors: Shunsuke Saito Shohei Okubo Taiki Matsuoka Shotaro Hirota Shohei Yokoyama Yuta Kanazawa Yusuke Takei Masahiro Tezuka Go Tsuchiya Taisuke Konishi Ikuko Shibasaki Koji Ogata Hirotsugu Fukuda Source Type: research
Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device
J Cardiol. 2023 Nov 3:S0914-5087(23)00270-8. doi: 10.1016/j.jjcc.2023.10.008. Online ahead of print.ABSTRACTThe importance of temporary mechanical circulatory support for treating acute heart failure with cardiogenic shock is increasingly recognized, and Impella (Abiomed, Danvers, MA, USA) has received particular attention in this regard. Impella is an axial flow left ventricular assist device (LVAD) built into the tip of a catheter. It is inserted via a peripheral artery and implanted into the left ventricle. Although the morphology of Impella is different from a typical LVAD, it has similar actions and effects as an LVAD...
Source: Journal of Cardiology - November 5, 2023 Category: Cardiology Authors: Shunsuke Saito Shohei Okubo Taiki Matsuoka Shotaro Hirota Shohei Yokoyama Yuta Kanazawa Yusuke Takei Masahiro Tezuka Go Tsuchiya Taisuke Konishi Ikuko Shibasaki Koji Ogata Hirotsugu Fukuda Source Type: research
Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device
J Cardiol. 2023 Nov 3:S0914-5087(23)00270-8. doi: 10.1016/j.jjcc.2023.10.008. Online ahead of print.ABSTRACTThe importance of temporary mechanical circulatory support for treating acute heart failure with cardiogenic shock is increasingly recognized, and Impella (Abiomed, Danvers, MA, USA) has received particular attention in this regard. Impella is an axial flow left ventricular assist device (LVAD) built into the tip of a catheter. It is inserted via a peripheral artery and implanted into the left ventricle. Although the morphology of Impella is different from a typical LVAD, it has similar actions and effects as an LVAD...
Source: Journal of Cardiology - November 5, 2023 Category: Cardiology Authors: Shunsuke Saito Shohei Okubo Taiki Matsuoka Shotaro Hirota Shohei Yokoyama Yuta Kanazawa Yusuke Takei Masahiro Tezuka Go Tsuchiya Taisuke Konishi Ikuko Shibasaki Koji Ogata Hirotsugu Fukuda Source Type: research
Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device
J Cardiol. 2023 Nov 3:S0914-5087(23)00270-8. doi: 10.1016/j.jjcc.2023.10.008. Online ahead of print.ABSTRACTThe importance of temporary mechanical circulatory support for treating acute heart failure with cardiogenic shock is increasingly recognized, and Impella (Abiomed, Danvers, MA, USA) has received particular attention in this regard. Impella is an axial flow left ventricular assist device (LVAD) built into the tip of a catheter. It is inserted via a peripheral artery and implanted into the left ventricle. Although the morphology of Impella is different from a typical LVAD, it has similar actions and effects as an LVAD...
Source: Journal of Cardiology - November 5, 2023 Category: Cardiology Authors: Shunsuke Saito Shohei Okubo Taiki Matsuoka Shotaro Hirota Shohei Yokoyama Yuta Kanazawa Yusuke Takei Masahiro Tezuka Go Tsuchiya Taisuke Konishi Ikuko Shibasaki Koji Ogata Hirotsugu Fukuda Source Type: research
Dynamic changes in echocardiographic parameters in acute decompensated heart failure: REALITY-ECHO
CONCLUSIONS: Echocardiographic parameters show a dynamic change in the very acute phase of AHF. Several parameters, such as the transmitral flow and TRPG might be useful in monitoring favorable hemodynamic change.PMID:37884192 | DOI:10.1016/j.jjcc.2023.10.007 (Source: Journal of Cardiology)
Source: Journal of Cardiology - October 26, 2023 Category: Cardiology Authors: Saori Uchiyama Misako Toki Takeshi Kitai Kenji Yoshioka Akihiro Hayashida Kiyoshi Yoshida Yuya Matsue Masayoshi Yamamoto Tohru Minamino Nobuyuki Kagiyama Source Type: research
Dynamic changes in echocardiographic parameters in acute decompensated heart failure: REALITY-ECHO
CONCLUSIONS: Echocardiographic parameters show a dynamic change in the very acute phase of AHF. Several parameters, such as the transmitral flow and TRPG might be useful in monitoring favorable hemodynamic change.PMID:37884192 | DOI:10.1016/j.jjcc.2023.10.007 (Source: Journal of Cardiology)
Source: Journal of Cardiology - October 26, 2023 Category: Cardiology Authors: Saori Uchiyama Misako Toki Takeshi Kitai Kenji Yoshioka Akihiro Hayashida Kiyoshi Yoshida Yuya Matsue Masayoshi Yamamoto Tohru Minamino Nobuyuki Kagiyama Source Type: research
Dynamic changes in echocardiographic parameters in acute decompensated heart failure: REALITY-ECHO
CONCLUSIONS: Echocardiographic parameters show a dynamic change in the very acute phase of AHF. Several parameters, such as the transmitral flow and TRPG might be useful in monitoring favorable hemodynamic change.PMID:37884192 | DOI:10.1016/j.jjcc.2023.10.007 (Source: Journal of Cardiology)
Source: Journal of Cardiology - October 26, 2023 Category: Cardiology Authors: Saori Uchiyama Misako Toki Takeshi Kitai Kenji Yoshioka Akihiro Hayashida Kiyoshi Yoshida Yuya Matsue Masayoshi Yamamoto Tohru Minamino Nobuyuki Kagiyama Source Type: research
Dynamic changes in echocardiographic parameters in acute decompensated heart failure: REALITY-ECHO
CONCLUSIONS: Echocardiographic parameters show a dynamic change in the very acute phase of AHF. Several parameters, such as the transmitral flow and TRPG might be useful in monitoring favorable hemodynamic change.PMID:37884192 | DOI:10.1016/j.jjcc.2023.10.007 (Source: Journal of Cardiology)
Source: Journal of Cardiology - October 26, 2023 Category: Cardiology Authors: Saori Uchiyama Misako Toki Takeshi Kitai Kenji Yoshioka Akihiro Hayashida Kiyoshi Yoshida Yuya Matsue Masayoshi Yamamoto Tohru Minamino Nobuyuki Kagiyama Source Type: research
